Ilepatril TFA
Ilepatril TFA is a dual inhibitor of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP), exhibiting physiological effects such as enhanced natriuresis and vasodilation. In animal studies and early clinical trials, Ilepatril TFA has demonstrated the ability to improve insulin sensitivity and metabolic abnormalities, suggesting its potential value in the treatment of cardiovascular and metabolic diseases.
Product Specifications
Purity
99.74% (May vary between batches)
Smiles
C ([C@@H]1CCC[C@@H]2C3C=CC=CC=3C[C@@H] (C (N12) =O) NC (=O) [C@H] (C (C) C) SC (=O) C) (=O) O.C (=O) (O) C (F) (F) F
Molecular Formula
C24H29F3N2O7S
Molecular Weight
546.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RA0555-C.5 0.5 mL
AFP (Alpha Fetoprotein) (Hepatocellular/Germ Cell Tumor Marker) ; Clone SPM334 (Concentrate)
Sign In for Pricing
View Details K6275803 1.0 µg DNA
Vom1r96 sgRNA CRISPR Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
485371 100 µL
MAP4K2 (Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2)
Sign In for Pricing
View Details MBS6305635-01 0.2 mL
HBQ1, NT (HBQ1, Hemoglobin subunit theta-1, Hemoglobin theta-1 chain, Theta-1-globin) (PE)
Sign In for Pricing
View Details